Investors must take note of Dynavax Technologies Corp’s (DVAX) performance last week, which was -7.55%.

On Tuesday, Dynavax Technologies Corp (NASDAQ: DVAX) was -5.92% drop from the session before settling in for the closing price of $12.49. A 52-week range for DVAX has been $9.74 – $14.63.

Annual sales at Healthcare sector company grew by 177.58% over the past five years. When this article was written, the company’s average yearly earnings per share was at 69.00%. With a float of $118.47 million, this company’s outstanding shares have now reached $125.45 million.

Let’s look at the performance matrix of the company that is accounted for 405 employees. In terms of profitability, gross margin is 82.17%, operating margin of -0.75%, and the pretax margin is 11.13%.

Dynavax Technologies Corp (DVAX) Insider and Institutional Ownership

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Dynavax Technologies Corp stocks. The insider ownership of Dynavax Technologies Corp is 4.66%, while institutional ownership is 101.70%. The most recent insider transaction that took place on Mar 24 ’25, was worth 140,000. In this transaction President & COO of this company sold 10,000 shares at a rate of $14.00, taking the stock ownership to the 8,078 shares. Before that another transaction happened on Mar 24 ’25, when Company’s Officer proposed sale 10,000 for $14.00, making the entire transaction worth $140,000.

Dynavax Technologies Corp (DVAX) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.09 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 69.00% per share during the next fiscal year.

Dynavax Technologies Corp (NASDAQ: DVAX) Trading Performance Indicators

You can see what Dynavax Technologies Corp (DVAX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 9.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.27. Likewise, its price to free cash flow for the trailing twelve months is 24.27.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.17, a number that is poised to hit 0.04 in the next quarter and is forecasted to reach 0.56 in one year’s time.

Technical Analysis of Dynavax Technologies Corp (DVAX)

Dynavax Technologies Corp (NASDAQ: DVAX) saw its 5-day average volume 2.7 million, a positive change from its year-to-date volume of 2.23 million. As of the previous 9 days, the stock’s Stochastic %D was 11.53%. Additionally, its Average True Range was 0.48.

During the past 100 days, Dynavax Technologies Corp’s (DVAX) raw stochastic average was set at 7.84%, which indicates a significant increase from 4.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.44% in the past 14 days, which was higher than the 29.59% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $13.34, while its 200-day Moving Average is $12.08. Nevertheless, the first resistance level for the watch stands at $12.49 in the near term. At $13.23, the stock is likely to face the second major resistance level. The third major resistance level sits at $13.65. If the price goes on to break the first support level at $11.33, it is likely to go to the next support level at $10.91. The third support level lies at $10.17 if the price breaches the second support level.

Dynavax Technologies Corp (NASDAQ: DVAX) Key Stats

There are 124,071K outstanding shares of the company, which has a market capitalization of 1.46 billion. As of now, sales total 277,250 K while income totals 27,310 K. Its latest quarter income was 72,030 K while its last quarter net income were 7,050 K.